Assistant Professor

Tel: (901) 523-8990


  • Other, VCU, Richmond, VA, Interventional Cardiology
  • Other, University of Louisville , KY, Cardiology
  • Other, Brigham &Women /Harvard, Boston MA, Research/Imaging fellowship
  • Other, Yale University New Haven CT, Research/Nuclear fellowship
  • Other, Duke University Durham NC, Internal Medicine Residency
  • M.D., Aga Khan University Pakistan, Medicine


  1. Shah R. Bioresorbable Vascular Scaffolds and Stent Thrombosis. Annals of Internal Medicine 2016 (In-press).
  2. Shah R. Linagliptin for elderly patients with type 2 diabetes.. Lancet. 2014 Jan 25;383(9914):306-7.
  3. Shah R, McMurray JM, Kober L, Pfeffer MA. Cardiac Structure and Function in Diabetics with Acute Myocardial infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both: the VALIANT Echo Study. JACC. 2007. 49(9); S1: A42-A98..
  4. Chung LH, Shah R, Hou LJ, Yeh HI. Role Of Regional Geometric Dyssynchrony By Real-time Three-dimensional Echocardiography As A Determinant Of Functional Mitral Regurgitation In Patients With Acute Myocardial Infarction. Circulation. 2007;116:II-764..
  5. Shah, R. Shelton MR.. Lesson of the month 1: broken heart in the intensive care unit. Clinical Medicine. 2014; 14 (4)..
  6. Shah R, Keough LA, Belalcazar-Portacio A, Ramanathan KB.. Ticagrelor as an alternative in clopidogrel-associated neutropenia.. Platelets. 2014 Jan 16;.
  7. Shah R, Khan MR, Matin K.. Preventive angioplasty in myocardial infarction.. New England J Med 2014;370(3):281.
  8. Shah R, Duncan S. Ramanathan KB.. Cocaine induced ST elevation MI.. Acute Med. 2014;13(2):72-3.
  9. Shah R, Matin K.. New oral anticoagulants in patients with atrial fibrillation.. Lancet. 2014;384:23-24.
  10. Shah R. Myocardial ischemic events in 'real world' patients treated with dabigatran.. Am J Med; 2014 Oct;127(10):e19.
  11. Shah R, Roberts KM, Ramanathan KB.. Influence of Chronic Kidney Disease on Warfarin Therapy for Atrial Fibrillation. JAMA. 2014;311(24):2542..
  12. Shah R, Mooney MA.. Complete versus culprit-only revascularisation for ST-segment elevationmyocardial infarction. Heart 2016.
  13. Shah R, Burg MM, Vashist A, Collins D, Liu J, Jadbabaie F, Graeber B, Earley C, Lampert R, Soufer R.. C-reactive protein and vulnerability to mental stress-induced myocardial ischemia.. Molecular Medicine (2006)12;10..
  14. Shah R, Wang Y, Foody JM.. Gender and racial difference in the outcomes and guideline-based management of troponin only positive acute myocardial infarction in older persons. Am J Geriatr Cardiology (2006)15;5..
  15. Shah R, Wang Y, Foody JM.. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.. American Journal of Cardiology 2008 Jan 15;101(2):217-222..
  16. Shah R.. Pioglitazone vs glimepiride in the PERISCOPE trial. JAMA. 2008 Aug 20;300(7):787-8..
  17. Shah R.. Protease-activated receptors in cardiovascular health and diseases.. Am Heart J. 2009 Feb;157(2):253-62.
  18. Shah R, Rashid A, Deam AG.. Dangerous cold Beverages.. Am J Med; 2014. 127(7):e3-4.
  19. Shah, R.. Renal denervation for resistant hypertension-the Symplicity HTN-1 study.. Lancet.2014; 383(9932):1885.
  20. Shah R, Khan, MR.. Comparative safety of vascular closure devices.. Annals of internal Medicine. 2014:160(6):438..
  21. Shah R.. Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome. J Am Coll Cardiol Intv. 2016;9(14):1517-1518.
  22. Foody JM, Shah R, Galusha D, Greenspan M, Masoudi FA, Havranek EP, Krumholz HM.. Statins and mortality among elderly patients hospitalized with heart failure.. Circulation. 2006; 113:1086 – 1092..
  23. Shah R, Wang Y, Masoudi FA, Havranek EP, Foody JM.. Prognosis of troponin only positive myocardial infarction in elderly. Crit Pathways in Cardiol 2006;5: 160-166.
  24. Shah,R. Endothelins in Health and Diseases. Eur J Intern Med. 2007 Jul;18(4):272-82.
  25. Shah R. Routine Ischemic Work-up for Patients with New Onset Heart Failure. JACC 2016 (In press)..
  26. Shah R, et al.. Meta-Analysis Comparing Complete Revascularization versus Infarct Related Only Strategies for Patients with ST-Segment Elevation Myocardial Infarction and Multi-vessel Coronary Artery Disease. American Journal of Cardiology 2016 (In press).
  27. Shah R.. Invasive Strategy for Acute Coronary Syndrome in The Very Elderly. Lancet 2016.
  28. Shah R , Rogers KC, Ahmed AJ, King BJ, Rao SV.. Effect of Post–Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis. Meta-Analysis of Randomized Controlled Trials. J Am Coll Cardiol Intv. 2016.
  29. Shah R, Foody J. Caring for the advanced elderly with acute coronary syndromes. Cardiology Reports. 2006; 8(4): 289-95.
  30. Shah, R. Optimum technique to reduce risk of stent thrombosis. Lancet, 388 (10040), 127, 2016.
  31. Shah, R, Rogers, KC, Ahmed, AJ, King, BJ, Rao, SV. Effect of Post-Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis: Meta-Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv, 9 (13), 1313-20, 2016.
  32. Shah, R, Rashid, A, Mizeracki, A. An Elderly Unresponsive Patient. JAMA, 315 (17), 1896-7, 2016.
  33. Shah, R, Ramos-Bondy, B, Mizeracki, A. Risk of stent thrombosis with bioresorbable vascular scaffolds. Lancet, 387 (10031), 1903, 2016.
  34. Shah, R, Khan, MR, Holt, LC. An Elderly Patient With Palpitation and a Negative Nuclear Stress Test Result. JAMA Intern Med, 176 (4), 542-4, 2016.
  35. Shah, R, John, E, Fan, TH, Ruff, G, Rehan Khan, M, Holt, LC. A Patient with Metastatic Small-Cell Lung Cancer and Giant Right Ventricular Mass. Echocardiography, 33 (3), 491-3, 2016.
  36. Shah, R, Qualls, Z. Diaphragmatic stimulation caused by cardiac resynchronization treatment. CMAJ, 2016.
  37. Shah, R, Rogers, KC, Matin, K, Askari, R, Rao, SV. An updated comprehensive meta-analysis of bivalirudin vs heparin use in primary percutaneous coronary intervention. Am Heart J, 171 (1), 14-24, 2016.
  38. Rao SV, Shah R. The Fuzzy Math of Anticoagulation and Access Site: When 1 + 1 Does Not Always Equal 2 (Editorial).. JACC Cardiovascular interventions., 2016.
  39. Shah R. Invasive strategy in acute coronary syndrome. Lancet, 387 (387), 2503, 2016.
  40. Shah, R. Bivalirudin in Acute Coronary Syndromes. N Engl J Med, 374 (3), 285, 2016.
  41. Shah, R, Gardner, JD. Radial versus femoral access for cardiac catheterisation. Lancet, 386 (10011), 2392-3, 2015.
  42. Shah, R, Berzingi, C, Fan, TH, Askari, R, Khan, MR. Cocaine-Induced Acute Aortic Dissection. J Emerg Med, 49 (3), e87-9, 2015.
  43. Shah, R. Bivalirudin versus heparin use for patients undergoing PPCI. Lancet, 385 (9982), 2045, 2015.
  44. Shah, R. β blockers in patients with heart failure and atrial fibrillation. Lancet, 385 (9978), 1618, 2015.
  45. Shah, R, Khan, MR, Fan, TH, Ruff, G, Ramanathan, KB. An 81-year-old man with an abnormal right-sided heart shadow on chest radiograph. Chest, 147 (2), e52-5, 2015.
  46. Shah, R. Fractional flow reserve-guided PCI. N Engl J Med, 372 (1), 94-5, 2015.
  47. Shah, R, Deam, AG. Wide complex tachycardia in a patient with a family history of sudden death. JAMA Intern Med, 175 (1), 128-31, 2015.
  48. Shah, R, Slomka, T, Rogers, KC. Dual antiplatelet treatment after stenting. Lancet, 385 (9965), 326, 2015.